Annual Operating Expenses
$67.31 M
-$7.32 M-9.81%
31 December 2023
Summary:
ADMA Biologics annual total operating expenses is currently $67.31 million, with the most recent change of -$7.32 million (-9.81%) on 31 December 2023. During the last 3 years, it has risen by +$7.76 million (+13.04%). ADMA annual operating expenses is now -9.81% below its all-time high of $74.63 million, reached on 31 December 2022.ADMA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$20.02 M
+$1.77 M+9.69%
30 September 2024
Summary:
ADMA Biologics quarterly total operating expenses is currently $20.02 million, with the most recent change of +$1.77 million (+9.69%) on 30 September 2024. Over the past year, it has increased by +$3.17 million (+18.80%). ADMA quarterly operating expenses is now -1.06% below its all-time high of $20.24 million, reached on 31 December 2022.ADMA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +18.8% |
| 3 y3 years | +13.0% | +19.9% |
| 5 y5 years | +115.3% | +145.0% |
ADMA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.8% | +13.0% | -1.1% | +25.4% |
| 5 y | 5 years | -9.8% | +115.3% | -1.1% | +145.0% |
| alltime | all time | -9.8% | >+9999.0% | -1.1% | >+9999.0% |
ADMA Biologics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.02 M(+9.7%) |
| June 2024 | - | $18.25 M(+5.6%) |
| Mar 2024 | - | $17.29 M(+2.6%) |
| Dec 2023 | $67.31 M(-9.8%) | $16.85 M(+5.5%) |
| Sept 2023 | - | $15.97 M(-7.0%) |
| June 2023 | - | $17.16 M(-0.9%) |
| Mar 2023 | - | $17.33 M(-14.4%) |
| Dec 2022 | $74.63 M(+25.3%) | $20.24 M(+6.7%) |
| Sept 2022 | - | $18.97 M(+12.0%) |
| June 2022 | - | $16.94 M(-8.3%) |
| Mar 2022 | - | $18.48 M(+10.6%) |
| Dec 2021 | $59.55 M(+29.9%) | $16.70 M(+12.7%) |
| Sept 2021 | - | $14.82 M(+1.7%) |
| June 2021 | - | $14.58 M(+8.5%) |
| Mar 2021 | - | $13.44 M(+11.4%) |
| Dec 2020 | $45.84 M(+46.6%) | $12.07 M(-1.3%) |
| Sept 2020 | - | $12.22 M(+7.1%) |
| June 2020 | - | $11.42 M(+12.6%) |
| Mar 2020 | - | $10.14 M(+24.1%) |
| Dec 2019 | $31.27 M(-10.9%) | $8.17 M(-2.2%) |
| Sept 2019 | - | $8.36 M(+12.8%) |
| June 2019 | - | $7.41 M(+1.0%) |
| Mar 2019 | - | $7.33 M(-22.5%) |
| Dec 2018 | $35.08 M(+9.4%) | $9.46 M(+6.8%) |
| Sept 2018 | - | $8.86 M(+5.1%) |
| June 2018 | - | $8.43 M(+1.2%) |
| Mar 2018 | - | $8.33 M(-14.8%) |
| Dec 2017 | $32.06 M | $9.78 M(+24.3%) |
| Sept 2017 | - | $7.87 M(+5.3%) |
| June 2017 | - | $7.47 M(+7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $6.95 M(+32.2%) |
| Dec 2016 | $21.63 M(+17.7%) | $5.26 M(+6.4%) |
| Sept 2016 | - | $4.94 M(-23.0%) |
| June 2016 | - | $6.42 M(+28.0%) |
| Mar 2016 | - | $5.02 M(-2.4%) |
| Dec 2015 | $18.38 M(+1.0%) | $5.14 M(-4.9%) |
| Sept 2015 | - | $5.40 M(+33.8%) |
| June 2015 | - | $4.04 M(+6.4%) |
| Mar 2015 | - | $3.80 M(-10.5%) |
| Dec 2014 | $18.19 M(+13.1%) | $4.24 M(+19.9%) |
| Sept 2014 | - | $3.54 M(-14.7%) |
| June 2014 | - | $4.15 M(-33.8%) |
| Mar 2014 | - | $6.27 M(+34.5%) |
| Dec 2013 | $16.09 M(+92.5%) | $4.66 M(+60.0%) |
| Sept 2013 | - | $2.91 M(-42.9%) |
| June 2013 | - | $5.10 M(+49.4%) |
| Mar 2013 | - | $3.41 M(-8.0%) |
| Dec 2012 | $8.36 M(>+9900.0%) | $3.71 M(+24.7%) |
| Sept 2012 | - | $2.98 M(+224.9%) |
| June 2012 | - | $915.60 K(+21.0%) |
| Mar 2012 | - | $756.40 K(+9013.3%) |
| Dec 2011 | - | $8300.00(+59.6%) |
| Sept 2011 | - | $5200.00(-55.6%) |
| June 2011 | $26.50 K(+29.3%) | $11.70 K(+138.8%) |
| Mar 2011 | - | $4900.00(-5.8%) |
| Dec 2010 | - | $5200.00(+13.0%) |
| Sept 2010 | - | $4600.00(-39.5%) |
| June 2010 | - | $7600.00(+58.3%) |
| June 2010 | $20.50 K | - |
| Mar 2010 | - | $4800.00(+11.6%) |
| Dec 2009 | - | $4300.00 |
FAQ
- What is ADMA Biologics annual total operating expenses?
- What is the all time high annual operating expenses for ADMA Biologics?
- What is ADMA Biologics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ADMA Biologics?
- What is ADMA Biologics quarterly operating expenses year-on-year change?
What is ADMA Biologics annual total operating expenses?
The current annual operating expenses of ADMA is $67.31 M
What is the all time high annual operating expenses for ADMA Biologics?
ADMA Biologics all-time high annual total operating expenses is $74.63 M
What is ADMA Biologics quarterly total operating expenses?
The current quarterly operating expenses of ADMA is $20.02 M
What is the all time high quarterly operating expenses for ADMA Biologics?
ADMA Biologics all-time high quarterly total operating expenses is $20.24 M
What is ADMA Biologics quarterly operating expenses year-on-year change?
Over the past year, ADMA quarterly total operating expenses has changed by +$3.17 M (+18.80%)